SEC Filing: Form 8-K Current report Post date May 8, 2025 Post categories In Uncategorized Filed: 2025-05-08 00:00:00 Filing Summary: Filing Summary Filing Details: SEC Filing Detail Post navigation ←Previous post:VYNE Therapeutics Provides Update on VYN202 Program→Next post:VYNE Therapeutics Reports 2025 First Quarter Financial Results and Provides Business Update
VYNE Therapeutics
VYNE Therapeutics